12th International Conference on cGMP


cGMP: Generators, Effectors and
Therapeutic Implications

Pre-final Program (May 8, 2026)

Thursday, June 18, 2026

13:00-13:50 Registration & Welcome Reception
13:50 Friedrich W. Herberg,
Kassel
Welcome to Kassel
13:55 Franz Hofmann,
München
Welcome from the Leopoldina
S1 | Session 1:
Clinical Translation: NP-based principles
Chairs:
Michaela Kuhn, Würzburg
Franz Hofmann, München
S1-01 14:00 Adam Snook,
Philadelphia
Prevention of Gastrointestinal Cancer Recurrence with GUCY2C-Directed Vaccines
S1-02 14:20 Lori Morton,
Tarrytown
REGN7544, an investigational first-in-class, fully human natriuretic peptide receptor 1-blocking monoclonal antibody for hypovolemic and hypotensive disorders
S1-03 14:40 Michael Nyberg,
Copenhagen
A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction
S1-04 15:00 Ana Calejo,
Oslo
Targeting resistant hypertension with allosteric modulator of GC‑A
15:20-15:50 COFFEE BREAK
S2 | Session 2:
Clinical Translation: NO-GC targeting drugs
Chairs:
Peter Sandner, Wuppertal
Roland Seifert, Hannover
S2-01 15:50 Stefano Corda,
Basel
Vericiguat, Victoria, Victor: sGC stimulator therapy in heart failure
S2-02 16:10 Robert Lawatscheck,
Berlin
Efficacy and safety of the SGC activator Nurandociguat in patients with CKD: the phase 2b study ALPINE-1
S2-03 16:30 Ubaldo Martin,
Waltham
Development and clinical function of the inhaled sGC activator mosliciguat in PH
S2-04 16:50 Thorsten Leucker,
Baltimore
Targeting Impaired NO-sGC-cGMP Signaling With Vericiguat Improves Coronary Endothelial Function in Patients With Metabolic Syndrome or Type 2 Diabetes
S2-05 17:10 Philipp Ellinger,
Wuppertal
Systematic analysis of disease-causing sGC mutations with sGC stimulators and sGC activators
17:30-18:00 GROUP PHOTO

18:00-20:00 GUIDED POSTER SESSION I
(poster numbers 01-22)
Chairs: Miriam Cortese-Krott and Peter Sandner
19:00-21:00 SNACKS AND REFRESHMENTS
MML | Ferid Murad
Memorial Lecture
Chair:
Miriam Cortese-Krott, Tübingen
MML-01
21:00-21:45
Lorenzo Berra,
Boston
Revisiting Inhaled Nitric Oxide: From Pulmonary Vasodilator to Targeted Pulmonary Therapy


Friday, June 19, 2026

S3 | Session 3:
NO/ NO-GC
regulation and functions
Chairs:
Andreas Friebe, Würzburg
Annie Beuve, Newark
S3-01 09:00 Dennis Stuehr,
Cleveland
Illuminating the Multi-step Maturation Process of sGC that Controls its Capacity for cGMP Production in Mammals
S3-02 09:20 Michael Marletta,
Berkeley
The Influence of sGC Conformation on Stimulator Function
S3-03 09:40 Daniela Wenzel,
Bochum
Beta arrestin 1 and sGC: Implications for pulmonary hypertension
S3-04 10:00 Brant Isakson,
Charlottesville
Lymphatic endothelial alpha globin promotes cardiac hypertrophy and T cell accumulation in the heart during cardiometabolic heart failure
S3-05 10:20 Chen Guang Wei,
London
Exploratory assessment of mechanisms of action of long-term inorganic nitrate supplementation in hypertensive patients with and without left ventricular hypertrophy
10:40-11:10 COFFEE BREAK
S4 | Session 4:
Rising stars
in cGMP research
Chairs:
Peter Sandner, Wuppertal
Robert Lukowski, Tübingen
S4-01 11:10 Anthea Lo Bue,
Tübingen
Endothelial cell eNOS regulates sodium excretion in the kidney as determined in endothelial cell-specific eNOS KO and KI mice
S4-02 11:25 Alexandra Fachinger,
Kassel
Isoform-Specific Modulation of PKG I Activity by the Small Molecule Inhibitor Rp-8-Br-PET-cGMPS: Elucidating the Mechanistic Roles of the Individual Cyclic Nucleotide Binding Domains
S4-03 11:40 Rieke Wellpott,
Regensburg
Analysis of PKGI’s dynamic landscape using single-molecule FRET measurements
S4-04 11:55 Katharina Paulus,
Tübingen
Proteomic analysis reveals potential new downstream interactors of the cardiac cGMP pathway under healthy and I/R conditions
12:10-13:30 POSTER SESSION II
(all numbers)
12:10-13:30 SNACKS AND REFRESHMENTS
13:30-16:30 FREE TIME
16:30-17:00 COFFEE BREAK
S5 | Session 5:
Systemic and local effects of NP/NPR
Chairs:

Lise Roman Moltzau, Oslo
Jens Schlossmann, Regensburg
S5-01 17:00 Achim Schmidtko,
Frankfurt
CNP/Npr2 signaling in sensory neurons contributes to pain processing
S5-02 17:20 Xin-Yun Huang,
New York
Structural biochemistry of activation of GC-A by hormone and therapeutic antibodies
S5-03 17:40 Kristen J. Bubb,
Melbourne
C-type natriuretic peptide reduces blood pressure and restores placental angiogenesis in a mouse model of preeclampsia
S5-04 18:00 Robert Rose,
Calgary
Natriuretic peptide dependent cGMP signaling in the heart protects against atrial remodeling, sinoatrial node dysfunction, and atrial fibrillation
S5-05 18:20 Swati Dabral,
Würzburg
C-type natriuretic peptide – cyclic GMP Axis in Pulmonary Fibrosis: From Disease Mechanisms to Therapeutic Targeting
18:40-19:45 SNACKS AND REFRESHMENTS
EL | Evening Lecture Chair:
Adrian Hobbs, London
EL-01
19:45-20:30
Michaela Kuhn,
Würzburg
A guided tour through long and short ANP-to-cyclic GMP circuits
20:30-22:00 GUIDED POSTER SESSION III
(poster numbers 23-44)
Chairs: Adrian Hobbs and Friedrich W. Herberg


Saturday, June 20, 2026

S6 | Session 7:
CN crosstalk
by PDE
Chairs:
Finn Olav Levy, Oslo
Leila Gobejishvili, Louisville
S6-01 08:30 Atsuhiko Ichimura,
Kyoto
PDE3 inhibition boosts CNP-stimulated bone growth through intracellular Ca2+ signaling
S6-02 08:50 Jonathan C. Schisler,
Chapel Hill
PDE9A and cGMP/cAMP crosstalk as a target to restore mitophagy and prevent ataxia
S6-03 09:10 Andrea M. Isidori,
Rome
Metabolic actions of PDE5i in the control of glucose and lipid metabolism
S6-04 09:30 Kjetil W. Andressen,
Oslo
PDE regulation of mitochondrial cGMP
S6-05 09:50 Melody Atkins,
Paris
Primary cilium-elicited cGMP and cAMP signals antagonise each other to regulate cell polarity during neuronal migration
10:10-10:40 COFFEE BREAK
S7 | Session 7:
Monitoring cGMP
and PKG
in action
Chairs:
Friedrich W. Herberg, Kassel
Robert Lukowski, Tübingen
S7-01 10:40 Jin Zhang,
San Diego
Illuminating the Dynamic Biochemical Activity Architecture of the Cell
S7-02 11:00 Robert Feil,
Tübingen
Mechano-cGMP: A new mode of NO-cGMP signaling in the cardiovascular system
S7-03 11:20 Friederike Cuello,
Hamburg
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability to Cause Aortopathy: PRKG1 variants and inherited aortic disease
S7-04 11:40 Giuseppe Melacini,
Hamilton
Mechanism of Protein Kinase G Allosteric Inhibitors with Therapeutic Potential in Retinal Degeneration
S7-05 12:00 Akiyuki Nishimura,
Okazaki
TRPC6-mediated Zn2+ influx improves heart failure through PKG-mediated anti-fibrotic effect
12:20-13:50 POSTER SESSION IV
(all numbers)
12:20-13:50 SNACKS AND REFRESHMENTS
S8 | Session 8:
Non-canonical
(cGMP-related)
mechanisms
Chairs:
Miriam Cortese-Krott, Tübingen
Brant Isakson, Charlottesville
S8-01 13:50 Tohru Fukai,
Augusta
Exercise-induced SOD3-derived H2O2 Sulfenylates PKG1a to Restore cGMP-independent Vasodilation in type2 diabetes
S8-02 14:10 Nagaraj Kerur,
Columbus
cGMP, cGAMP, and Beyond: Cyclic Dinucleotide Signaling from Phage to Physiology
S8-03 14:30 Takaaki Akaike,
Sendai
Cyclo-octasulfur (S8): A potential signalling molecule produced by endothelial nitric oxide synthase
S8-04 14:50 Annie Beuve,
Newark
Endothelial soluble guanylyl cyclase: resistance is not futile!
S8-05 15:10 Adriana Szmidt-Jawrowska,
Toruń
Cyclic nucleotides in plants
15:30-16:00 COFFEE BREAK
S9 | Session 9:
Poster
Presentations “Rapid Fire”
Chairs:
Sheila Collins, Nashville
Michael Marletta, Berkeley
S9-01 16:00 3 to 5 selected posters from poster numbers 1-44 5 minute rapid fire oral presentations of selected posters
16:50-18:00 ORAL & POSTER PRIZE COMMITTEE MEETING
18:30-22:00 AWARD DINNER & CEREMONY

home | scientific organizers | city | program | further information | abstracts | registration | accomodation | sponsors | impressum | privacy